Laurent Humeau
Chief Tech/Sci/R&D Officer at INOVIO PHARMACEUTICALS, INC.
Net worth: 246 412 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Niranjan Y. Sardesai | M | 56 |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 15 years |
| Jacqueline Shea | M | 58 | 5 years | |
| Simon Benito | M | 79 | 21 years | |
| Jay Shepard | M | 65 | 4 years | |
| Wendy Yarno | F | 69 | 7 years | |
| Joann Peters | F | - |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 5 years |
| Ann Miller | M | 66 | 5 years | |
| David Weiner | M | 67 | 41 years | |
| Roger Dansey | M | 68 | 3 years | |
| Lota Zoth | F | 64 | 6 years | |
| Ted Ingemar Jakob Fjällman | M | 46 |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 2 years |
| Cheryl Elder | F | - | - | |
| Stephen Kemmerrer | M | - | 17 years | |
| Sangwoo Lee | M | 52 |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 4 years |
| Shawn D. Bridy | M | - | 6 years | |
| Thomas Hong | M | - | - | |
| Sang-Woo Lee | M | - |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 3 years |
| Jeffrey Skolnik | M | - | 8 years | |
| Maggie Campbell | F | - | 18 years | |
| Shawn Tomasello | F | 65 |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | - |
| Mark C. Twyman | M | 63 | 6 years | |
| Michael Sumner | M | 59 | 2 years | |
| Omar Khalil | M | - |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | 1 years |
| Samuel Broder | M | 79 |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | - |
| Peter Kies | M | 60 | 22 years | |
| Robert L. Crotty | M | 50 | 3 years | |
| Jennie Willson | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| J. Kim | M | 55 | 13 years | |
| Nancy Wysenski | F | 66 | 2 years | |
| George Bickerstaff | M | 68 | 1 years | |
| Thomas S. Kim | M | - | 10 years | |
| Jessica C. Lee | F | - | 16 years | |
| Angel Cabrera | M | 56 | 8 years | |
| Avtar Dhillon | M | 62 | 18 years | |
| Morton Collins | M | 88 | 11 years | |
| David Liebowitz | M | - | - | |
| Mark Bagarazzi | M | 63 | 9 years | |
| Mammen P. Mammen | M | 60 | 2 years | |
| Jennifer Laux | F | - | 5 years | |
| Scott M. White | M | - | 4 years | |
| Ami Shah Brown | M | - | 11 years | |
| Paul Stead | M | - | - | |
| Ben Matone | M | - | - | |
| Zane Yang | M | - | 2 years | |
| Michael W. Cordera | M | - | - | |
| Kate Broderick | M | - | 15 years | |
| Asli Gevgilili | M | - | 2 years | |
| Gene Kim | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 48 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Laurent Humeau
- Personal Network
